The nurse is caring for a client with hypertension, gastroesophageal reflux, and osteoarthritis. While performing a bedside assessment the nurse observes the client is alert and oriented to person, place, time, and situation, but is exhibiting signs of jaundice. The nurse should notify the healthcare provider (HCP) about which scheduled medication?

Choice A reason: Prednisone is a corticosteroid used for inflammatory conditions such as osteoarthritis. While long-term use of corticosteroids can cause multiple systemic side effects such as immunosuppression, osteoporosis, and hyperglycemia, jaundice is not a typical direct adverse effect of prednisone. Hepatic dysfunction is not commonly associated with prednisone use, so this medication is not the most concerning in the context of jaundice. Choice B reason: Omeprazole is a proton pump inhibitor used for gastroesophageal reflux disease. Its adverse effects are generally related to gastrointestinal symptoms, vitamin B12 deficiency, or increased risk of infections such as Clostridium difficile. Hepatotoxicity is rare with omeprazole, and jaundice is not a common manifestation of its side effects. Therefore, omeprazole is not the medication that requires urgent notification to the healthcare provider in this scenario. Choice C reason: Captopril is an ACE inhibitor used for hypertension. Its common adverse effects include cough, hyperkalemia, hypotension, and angioedema. Hepatic dysfunction is not a typical adverse effect of captopril, and jaundice is not directly associated with its use. Thus, captopril is not the medication of concern in this case. Choice D reason: Acetaminophen is widely used for pain management in osteoarthritis. However, it is metabolized in the liver, and excessive or prolonged use can lead to hepatotoxicity. Jaundice is a classic clinical sign of liver injury, which can occur due to acetaminophen-induced hepatocellular damage. Because the nurse has observed jaundice, acetaminophen is the most likely culprit among the scheduled medications. This finding requires immediate notification of the healthcare provider to prevent progression to acute liver failure.